Incidence and impact of disseminated intravascular coagulation in COVID-19 a systematic review and meta-analysis
| Autor: | Zhang-Yin Ming, Lili Luo, Ying Zhu, Wei Chen, Zhi-Peng Cheng, Yu Hu, Wenyi Lin, Xianghui Zhou |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
China
medicine.medical_specialty Poor prognosis Coronavirus disease 2019 (COVID-19) 030204 cardiovascular system & hematology Article 03 medical and health sciences 0302 clinical medicine PT prothrombin time Internal medicine Statistical significance medicine Humans DIC disseminated intravascular coagulation Infectious disease (athletes) APTT activated partial thromboplastin time COVID-19 coronavirus disease 2019 Disseminated intravascular coagulation SARS-CoV-2 business.industry Incidence Incidence (epidemiology) COVID-19 Hematology Disseminated Intravascular Coagulation medicine.disease FDP fibrin degradation products Pooled analysis 030220 oncology & carcinogenesis Meta-analysis CRP C-reactive protein business |
| Zdroj: | Thrombosis Research |
| ISSN: | 0049-3848 |
| Popis: | OBJECTIVES: Coronavirus disease 2019 (COVID-19) is a novel infectious disease, with significant morbidity and mortality. This meta-analysis is to evaluate the prevalence of disseminated intravascular coagulation (DIC) in COVID-19 patients and to determine the association of DIC with the severity and prognosis of COVID-19. METHODS: We searched the PubMed, EMBASE, and China National Knowledge Infrastructure (CNKI) database until August 12, 2020. The meta-analysis was performed using Stata 16.0 software. RESULTS: 14 studies were included in our meta-analysis. The pooled analysis revealed that the incidence of COVID-19 patients developing DIC was 3% (95%: 1%-5%, P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect